Table 2

 Baseline anthropometric and lung function data of study population (n = 37 children, 21 boys)

Without relapse(n = 28)With relapse(n = 9)
ICS, inhaled corticosteroid; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PEF, peak expiratory flow; FENO, fractional nitric oxide concentration in exhaled air.
Data are given as mean (range) except for the dose of ICS which is given as median. FENO is given as geometric mean with 95% confidence interval. None of the items differed significantly between children with and without relapse.
*After bronchodilation with 1000 μg terbutaline.
Age (years)12.2 (7.3–16.9)12.3 (10.0–15.8)
Atopy (n)218
Daily dose ICS(budesonide equivalent) μg400 (100–400)200 (100–400)
Height (m)1.53 (1.30–1.81)1.52 (1.44–1.66)
Weight (kg)10.2 (7.3–14.2)14.8 (8.5–25.8)
FEV1 (% pred)100 (73–134)99 (88–109)
FVC (% pred)102 (66–126)105 (87–118)
FEV1 (% pred) post*106 (80–139)107 (91–119)
FVC (% pred) post*103 (66–127)105 (78–118)
PEF (l/s)383 (195–600)426 (270–800)
PEF diurnal variabilty (%)5.6 (1–10)6.3 (3–11)
Baseline FENO (ppb)10.5 (7.3–14.2)14.8 (8.5–25.8)